Isaac Bentwich, M.D., is the Founder and CEO of Quris-AI, an artificial intelligence innovator that is disrupting the drug development process, enabling pharma companies to develop safer drugs, faster. A physician and entrepreneur, Bentwich has founded and led multiple Bio-AI technology companies that harness machine learning and advanced biology to drive revolutions in medicine, genomics, conservation, and longevity.

One of these, Rosetta Genomics (NASDAQ: ROSG), under his leadership analyzed the human genome, discovering hundreds of novel genes—more than all the universities in the world combined—and delivered novel cancer diagnostics based on these discoveries. Its subsidiary, Rosetta Green (TASE: RSTG), was acquired by Monsanto for $35M.

His passion is leading interdisciplinary teams of scientists and technologists at the intersection of AI and life sciences, driving solutions from conception to commercialization. Over the past three decades, he has founded and led four technology companies to global impact, including a NASDAQ IPO and successful acquisitions.

Alongside his work in science and technology, Dr. Bentwich is a longtime practitioner and teacher of yoga and meditation. This lifelong engagement with contemplative practice complements his entrepreneurial mission, reflecting a unique commitment to advancing both cutting-edge innovation and human wellbeing.